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EDITORIAL COMMENT
At a time when prototype pencardial valves have fallen by the wayside, and staunch believers feel there is indeed a need to revive such valves, this paper by Jamieson and Gerein is certainly most timely.
The emphasis of this paper is structural failure, and rightly so, since it has been the Achilles heel of pericardial valves. The results, with regard to freedom from structural failure in a follow-up period of 7 years, certainly seem encouraging. The authors stress that ttfe most common mode of failure is due to leaflet tear at the commissural post suture, where the mechanical stress is highest. However, it is surprising that tears and perforations did not appear to be influenced by the presence or absence of dystrophic calci- fication-similar findings had been noted by other pericardial valve enthusiasts. This could very well be true, because tears occurred before significant calcification set in. It is conceivable that, if tears are prevented, the problem of calcification may arise since it is inevitable that all biological tissues implanted for a sufficient length of time will eventually calcify and/or degenerate. In any case, even if calcification does play a role, hopefully this problem will soon be overcome since there are currently innumerable scientists addressing the issue of early calcification and degeneration of biological valves.
One important point highlighted by the authors is the observation that structural failure couldbe due to abrasions of the pericardium by the Dacron covering the stent and the pericardial leaflet coming into contact with the stent as the valve opens and closes. The manufacturers of the Mitroflow valve attribute this to the fact that Dacron has a ribbed side and a smooth side and that, in the standard valves, they have sewn the Dacron cloth with the ribbed side exposed. They contend this ribbed side is more traumatic to the leaflet; therefore, reversing the Dacron cloth presents the smooth side to the pericardial leaflets and solves the problem, Using this approach, their in vitro tests have shown no tears due to abrasions at a clinical time equivalent to 10 years (Figures 1 and 2) . 
MITROFLOW PERlCARDlAL BIOPROSTHESIS EXPERIENCE
There can be no doubt that the weak point in pericardial valves lies with the design. Therefore, all potential modes of failure have to be studied and the design modified accordingly. Minor changes such as those presented in this paper could have far-reaching results in our endeavor to prolong durability.
The performance of this valve warrants continued use and close observation of its long-term regults. 
